Associated Papers
CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor.
Duan L et al.
Scientific Reports, 2023
37759078 (PubMed )
Supplement: 41598_2023_43218_MOESM2_ESM.xlsx › Table_S1
Select a paper to view details